Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis
Author:
Funder
Commonwealth Fund
Publisher
Elsevier BV
Reference69 articles.
1. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014–16: cross sectional analysis;Naci;BMJ,2019
2. Generating comparative evidence on new drugs and devices before approval;Naci;Lancet,2020
3. Trends in prescription drug launch prices, 2008–2021;Rome;JAMA,2022
4. Prescribing at the primary care group level: census data and prescribing indicators;Lloyd;J Clin Pharm Ther,2001
5. Availability and coverage of new drugs in 6 high-income countries with health technology assessment bodies;Wouters;JAMA Intern Med,2024
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Boom or Bust—Toward Responsible Adoption of Innovation in Radiation Oncology;International Journal of Radiation Oncology*Biology*Physics;2025-07
2. Spending review leaves a greater need for clarity on healthcare priorities;BMJ;2025-06-12
3. Characteristics of professional society oncological drug evaluation in the Netherlands from 2016 to 2020: A retrospective analysis;Journal of Cancer Policy;2025-06
4. Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences;American Society of Clinical Oncology Educational Book;2025-06
5. Population health impact of NICE-recommended new drugs – Authors' reply;The Lancet;2025-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3